TAMSULOSIN HYDROCHLORIDE

Product NDC: 61919-298
11-digit product format: 619190298
Labeler code: 61919
Product ID: 61919-298_9cad4c43-5a9d-8fe8-e053-2a95a90a4d98
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: TAMSULOSIN HYDROCHLORIDE
Dosage form: CAPSULE
Route: ORAL
Labeler: DirectRX
Application: ANDA202433
Marketing category: ANDA
Marketing start: 2015-11-25
Marketing end: 0000-00-00
Substance: TAMSULOSIN HYDROCHLORIDE
Active strength: 0 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61919-298		I	Inactivated by FDA		2026-08-07
excluded package	package	61919-298	61919-298-30	I	Inactivated by FDA		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 32 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-298-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-298-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-298-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-298-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-298-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-298-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-298-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-298-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-298-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61919-298-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61919-298-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61919-298-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61919-298-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61919-298-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61919-298-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61919-298-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202433-001	TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB		2013-04-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A202433-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202433-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202433-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202433-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202433-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202433-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202433-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202433-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202433-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202433-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202433-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202433-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202433-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202433-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202433-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202433-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202433-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202433-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202433-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202433-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202433-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202433-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202433-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202433-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202433-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202433-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202433-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202433-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202433-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202433-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202433-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202433-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202433-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202433-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202433-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202433-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202433-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202433-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202433-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202433-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202433-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ee39297f-c54b-4394-13fa-e0de7b5b9070	Product name	4	20250305
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
ae349df8-97ce-a639-ed32-50a4cb01b1bd	Product name	4	20200313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-298-30	2023-01-30	C162847	48780-1	f386c649-b049-0266-e053-dadaa90a7c1a	TAMSULOSIN HYDROCHLORIDE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-298-30	TAMSULOSIN HYDROCHLORIDE	30 in 1 BOTTLE	CAPSULE	30		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-298-30	EA - Each	61919-298	c86c7b3b-712b-4f5c-9090-865c9b06b5aa	1	2017-11-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TAMSULOSIN HYDROCHLORIDE	ACTIVE INGREDIENT	11SV1951MR	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
TAMSULOSIN	ACTIVE MOIETY	G3P28OML5I	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-298	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECTRX]	2	Legacy NDC, 1 package rows	20200130_255eab95-a7aa-3a37-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	REMEDYREPACK INC.	a608ddc8-fe42-484e-b61f-307c60151138	2026-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	REMEDYREPACK INC.	b30e2bde-b20e-4899-a100-f44170d8165b	2026-06-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	59d0e07c-0018-4681-beb2-cb1c8e2637ee	2026-05-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	St. Marys Medical Park Pharmacy	6142d7b6-e5ea-1af0-e053-2991aa0a00cd	2026-05-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	DIRECT RX	7a420aca-31e6-8e0c-e053-2a91aa0a1be0	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	Direct_Rx	8de50eca-8cc5-082d-e053-2a95a90a346d	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	fd73ddfd-3773-45b2-9795-9e58744a6803	2026-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Redpharm Drug	4d481f6b-0232-d4af-e063-6394a90ad1af	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	f543f5d1-3348-4066-99a4-7a00aee1530d	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Rising Pharma Holdings, Inc.	a242c8dc-576e-4a1f-a9e7-a05d7ebc0e0a	2026-01-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Northwind Health Company, LLC	d9df4fe0-90ab-0d96-e053-2a95a90a5ff1	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Cardinal Health 107, LLC	0e3206ba-db3e-40b3-b46b-c7ae4703fdea	2025-10-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	f6b6aeab-bedd-4254-8811-4f65cf8a351f	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	6a2a4cc7-c88a-4555-a247-d1e63206ffc5	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	00bb2d71-1f21-494c-aa66-a82be3a0a8e6	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	1d70b04e-ca08-48d3-937b-eb701b40dd8a	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Preferred Pharmaceuticals, Inc.	82d65964-de00-42c2-baaa-cc3de744b8eb	2025-09-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Major Pharmaceuticals	f8302a6e-b8da-4931-a279-b49e37943816	2025-09-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	36b8c36f-22e5-40f5-a99a-411115f13df4	2025-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	cfd48327-a528-58cc-e053-2995a90a129f	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
11SV1951MR	TAMSULOSIN HYDROCHLORIDE	106463-17-6	TAMSULOSIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
863669	tamsulosin HCl 0.4 MG Oral Capsule	PSN	255eab95-a7aa-3a37-e054-00144ff8d46c	2
863669	tamsulosin hydrochloride 0.4 MG Oral Capsule	SCD	255eab95-a7aa-3a37-e054-00144ff8d46c	2
863669	tamsulosin HCl 0.4 MG Modified Release Oral Capsule	SY	255eab95-a7aa-3a37-e054-00144ff8d46c	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61919-298-30	61919029830	30 CAPSULE in 1 BOTTLE (61919-298-30)	30 capsule	2015-11-25	0000-00-00	No	No	Current